LEAP2 and Cognitive impairment: In our future study, we will recruit a larger cohort with a wider range of BMI and itemized MMSE scores to evaluate the diagnostic capacity of LEAP2/ghrelin imbalance in identifying hippocampus-related cognitive deficits during normal aging.